Prediction of diacerein inhibition activity against interleukin-1 receptors through docking method and tracing of pharmacokinetic profiles and their toxicity

Frengki Frengki, Vivi Sofia, Deddi Prima Putra, Fatma Sri Wahyuni, Daan Khambri, Henni Vanda

Abstract


IL-1 is one of the cytokines involved in joint diseases such as osteoarthritis. IL-1 plays a role in maintaining the balance of proteolytic proteins:MMPs and TIMPs inhibitors. Increased expression and uncontrolled IL-1 activity tend to increase the role of MMPs in degrading proteoglycans and joint tissue collagen. This study aims to reveal the interaction model of one of the osteoarthritis drugs, namely diacerein. A drug belongs to a group of disease-modifying osteoarthritis drugs (DMOADs) to suppressthe development of the disease rate, improving the structure and function of the cartilage and surrounding tissue. "In silico" digital test uses the technique of "molecular docking: used as a method of the approach using the MOE 2007.09 software application. The test material was in the form of a diacerein 3D structure and five control ligands, while the IL-1β / IL-1RI receptor template was downloaded from pdb.org (PDB ID: 1ITB). The ligand pharmacokinetic profile will also be displayed obtained through the ADMETSAR server. The docking results showed diacerein had the lowest docking score of -12.3285 kcal/mol with the strongest affinity, the best pharmacokinetic profile but more toxic. This study proves that the mechanism of diacerein inhibition of IL-1β / IL-1RI receptors is similar to dexamethasone, prednisolone,and minocycline.

Keywords


Diacerein; osteoarthritis; IL-1; in silico

Full Text:

PDF

References


Awaluddin, R., Muhtadi, W. K., Chabib, L., & Ikawati, Z. (2017).Molecular docking and ADME-toxicity studies of potential compounds of medicinal plants grown in Indonesia as an anti-rheumatoid arthritis Molecular Docking and ADME-Toxicity Studies of Potential Compounds of Medicinal Plants Grown In Indonesia as An Anti. AIP Conference Proceedings, 020033, 020033-1-020033–020039. https://doi.org/10.1063/1.4978106Bansal, T., Jaggi, M., Khar, R. K., Institutes, B. S. A. E., Talegaonkar, S., &Sciences, D. P. (2014). Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in Cancer Chemotherapy. Journal of Pharmacy and Pharmaceutical Sciences, 12 (1)(May), 46–78. https://doi.org/10.18433/J3RC77Bao, L., Hazari, S., & Mehra, S. (2012). Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. The American Journal of Pathology, 180(6), 2490–2503. https://doi.org/10.1016/j.ajpath.2012.02.024Fernández-moreno, M., Rego, I., Carreira-garcia, V., Blanco, F. J., & Coruña, A. (2008). Genetics in osteoarthritis. Current Genomics, 9(8), 542–547.Frengki, Putra, D. P., Wahyuni, F. S., & Khambri, D. (2018). Uji in vitro dan in silico senyawa 5,7,2’,5’-tetrahydroxy flavan-3-OL terhadap enzim alpha glucosidase. Jurnal Fitofarmaka Indonesia, 5(2), 279–283.Halim, S. A., & Jawad, M. (2015). Attempt to explore the binding mechanism of IL-1 β Inhibitors via molecular attempt to explore the binding mechanism of IL-1β inhibitors via molecular docking studies. Medical Chemistry, 5(10), 452–257. https://doi.org/10.4172/2161-0444.1000300Hopade, A. R. C., Ayyad, F. J. S., & Ore, Y. V. P. (2015). Molecular docking studies of phytocompounds from the phyllanthus species as potential chronic pain modulators. Scientia Pharmaceutica, 83(2), 243–267. https://doi.org/10.3797/scipharm.1408-10Jansen, G., Scheper, R. J., & Dijkmans, B. A. C. (2003). Multidrug resistance proteins in rheumatoid arthritis , role in disease-modifying antirheumatic drug efficacy and inflammatory processes : An overview Multidrug resistance proteins in rheumatoid arthritis , role in disease-modifying antirheumatic drug ef. Scandinavian Journal of Rheumatology, 32(May), 325–336. https://doi.org/10.1080/03009740310004333Lawson, M. A., Parrott, J. M., Mccusker, R. H., Dantzer, R., Kelley, K. W., & Connor, J. C. O. (2013). Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2 , 3-. Journal of Neuroinflammation, 10(1), 1–9. https://doi.org/10.1186/1742-2094-10-87Malik, A., Afaq, S., El-gamal, B., Ellatif, M. A., Hassan, W. N., & Dera, A. (2019). Molecular docking and pharmacokinetic evaluation of natural compounds as targeted inhibitors against Crz1 protein in Rhizoctonia solani. 15(4), 277–286. https://doi.org/10.6026/97320630015277Martel-pelletier, J., & Pelletier, J. (2010). Effects of diacerein at the molecular level in the osteoarthritis disease process. TherapeuticAdvances in Musculoskeletal Disease, 2(2), 95–104. Siddik, Z. H. (2003). Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene, 22, 7265–7279.Sofia, V., Ali, H., Rahmadian, R., & Amita, F. (2018). Ekspresi gen tissue inhibitor metalloproteinase-1 pada sel sinoviosit osteoartritis grade IV setelah pemberian diacerein. Jurnal Kesehatan Andalas, 7(1), 19–25.Sripathy, R., Anjana, D., Somashekara, N., Krishnaraju, A., Krishanu, S., Murali, M.,Verma, S. R., & Ramchand, C. N. (2012). In Silico , in vitro and in vivo assessment of safety and anti-inflammatory activity of curcumin research and development , Laila Pharmaceuticals Pvt . Ltd ., Chennai , Tamilnadu , India Research and Development , Laila Impex R and D Centre , Vijayawada ,. American Journal of Infectious Diseases, 8(1), 26–33.Svetlana, E., John, R., Fruehauf, P., Kim, A. H., Stroup, R., & Although, I. (1998). Levels taxol of Multidrug Breast and Doxorubicin ’ Resistance Cancer with in Vitro Expression to by Human Correlate Resistance. Clinical Cancer Research, 4(February), 389–398.Weber, M. A., Schiffrin, E. L., White, W. B., Mann, S., Lindholm, L. H., Kenerson, J. G., Flack, J. M., Carter, B. L., Pharm, D., Materson, B. J., &Ram, C. V. S. (2014). Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension. Journal of Clinical Hypertension, 16(1), 14–26. https://doi.org/10.1111/jch.12237




DOI: http://dx.doi.org/10.12928/pharmaciana.v10i3.16445

Article Metrics

Abstract view : 0 times
PDF - 0 times

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Frengki Frengki, Vivi Sofia, Deddi Prima Putra, Fatma Sri Wahyuni, Daan Khambri, Henni Vanda

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


 
Pharmaciana
ISSN Print: 2088-4559 | ISSN Online: 2477-0256
Website: http://journal.uad.ac.id/index.php/PHARMACIANA
Office: Faculty of  Pharmacy, Universitas Ahmad Dahlan
Jl. Prof. Dr. Soepomo, S.H., Janturan, Warungboto, Umbulharjo, Yogyakarta, Indonesia
Kode pos 55164
Email: pharmaciana@pharm.uad.ac.id